Saturday, October 31, 2026

Microsoft Stock Jumps 2% As Session Comes To An End On Wednesday, Outperforms Market

ViaNews Editorial Team

December 16, 2020

Microsoft Stock Jumps 2%  As Session Comes To An End On Wednesday, Outperforms Market

Shares of Microsoft jumped 2.71% to $219.93 at 15:37 EST on Wednesday, following yesterday's downward trend. The Nasdaq Stock Market is rising 0.65% to $12,677.50, after two consecutive sessions in a row of gains. This seems, up to now, a somewhat positive trend exchanging session today.

Microsoft's last close was $214.13, 5.88% below its 52-week high of $232.86.

News about Microsoft today

Yealink unveils new meetingbar a20 certified for Microsoft teams for small meeting spaces. According to today's article on Business Insider, "Announced at Microsoft Ignite 2020, the MeetingBar A20 is showing great features with the consistent Teams experience including one-touch join, whiteboard, and dual-screen support. ", ""It is exciting to see the Microsoft Teams Rooms on Android portfolio advance with the addition of the Yealink A20." said Albert Kooiman, Senior Director of Microsoft Teams Devices Partner Engineering and Certification. "

Microsoft's Sales

Microsoft's sales growth is 8.9% for the present quarter and 10.6% for the next. The company's growth estimates for the current quarter and the next is 8.6% and 13.6%, respectively.

Microsoft's Revenue

Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 147.11B for the twelve trailing months.

Microsoft's Stock Top and Bottom Yearly Value

Microsoft's stock is valued at $219.93 at 15:37 EST, below its 52-week high of $232.86 and way above its 52-week low of $132.52.

Microsoft's Moving Average

Microsoft's value is above its 50-day moving average of $213.15 and above its 200-day moving average of $208.65.

Previous days news about Microsoft

These are the 5 most important people who left Microsoft in 2020 - and 5 new power players who signed on. According to Business Insider on Sun Dec 13, "Shum's LinkedIn has listed the title of "visiting researcher" at Microsoft Research since March, implying that he's kept some relationship with the company even after stepping down from his role.", "Microsoft tried to acquire the US operations of video app TikTok, though the bid ultimately failed, and recently announced plans to pay $7.5 billion for video game publisher ZeniMax Media."

Microsoft and warner bros. pictures assemble all-star team in lebron james, bugs bunny and xbox to celebrate gaming and coding education inspired by the upcoming animated, live-action adventure 's.... According to Business Insider on Mon Dec 14, "There are also two film-themedMicrosoft Learnlessons, targeting more experienced coders, older teens, high school and college-aged students, and adults, that focus on how to useplayer stats to makereal-timedecisionsin the middle of a game. ", "ABOUT MICROSOFTMicrosoft (Nasdaq "MSFT" @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. "

Mindtree accelerates cloud business through global Microsoft azure experience center and new skills academy. According to Business Insider on Tue Dec 15, "Third, a global, Microsoft Excellence Academy will provide every Mindtree Mind technical professional training and certification on Azure technologies.", "The Microsoft go-to-market business unit is a component of Mindtree's multi-tiered initiative to support the continued demand of cloud services and solutions. "

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com